10x Genomics is trading at $72.53, down 4.69% in pre-market amid broader market pressure; no clear company-specific catalyst was identified. - Shares fell 5.65% on October 7 and 17.47% on October 6, extending the decline. - Rising Treasury yields and oil prices, inflation concerns, and Middle East supply risks weighed on markets, Reuters reported on October 7. - A report covered recent product milestones but did not link them to a share-price move.